Memphis Pharmaceuticals (Egypt) Price Prediction
| MPCI Stock | 52.25 0.47 0.89% |
Oversold Vs Overbought
35
Oversold | Overbought |
Using Memphis Pharmaceuticals hype-based prediction, you can estimate the value of Memphis Pharmaceuticals from the perspective of Memphis Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Memphis Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Memphis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Memphis Pharmaceuticals after-hype prediction price | EGP 52.25 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Memphis |
Memphis Pharmaceuticals Estimiated After-Hype Price Prediction Volatility
As far as predicting the price of Memphis Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Memphis Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Memphis Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Memphis Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Memphis Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Memphis Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Memphis Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.94 | 7.21 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
52.25 | 52.25 | 0.00 |
|
Memphis Pharmaceuticals Hype Timeline
Memphis Pharmaceuticals is now traded for 52.25on Egyptian Exchange of Egypt. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Memphis is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.94%. %. The volatility of related hype on Memphis Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 52.25. Assuming the 90 days trading horizon the next forecasted press release will be uncertain. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.Memphis Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Memphis Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Memphis Pharmaceuticals' future price movements. Getting to know how Memphis Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Memphis Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MPCI | Memphis Pharmaceuticals | 0.00 | 0 per month | 2.47 | 0.11 | 12.93 | (4.98) | 47.18 | |
| PACH | Paint Chemicals Industries | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EIUD | Egyptians For Investment | 0.00 | 0 per month | 1.85 | 0.10 | 5.00 | (4.55) | 9.76 | |
| GTHE | Global Telecom Holding | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ATLC | Al Tawfeek Leasing | 0.00 | 0 per month | 1.46 | 0.11 | 4.77 | (2.40) | 9.69 | |
| ORAS | Orascom Construction PLC | 0.00 | 0 per month | 1.17 | 0.06 | 3.79 | (2.18) | 15.06 | |
| EGAS | Natural Gas Mining | 0.00 | 0 per month | 2.95 | 0.12 | 8.96 | (5.00) | 39.94 | |
| EMFD | Emaar Misr for | 0.00 | 0 per month | 2.27 | (0.01) | 4.81 | (4.18) | 12.29 | |
| ATQA | Misr National Steel | 0.00 | 0 per month | 1.97 | 0.08 | 4.58 | (3.42) | 15.29 | |
| AIVCB | Al Arafa Investment | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Memphis Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Memphis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Memphis using various technical indicators. When you analyze Memphis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Story Coverage note for Memphis Pharmaceuticals
The number of cover stories for Memphis Pharmaceuticals depends on current market conditions and Memphis Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Memphis Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Memphis Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for Memphis Stock analysis
When running Memphis Pharmaceuticals' price analysis, check to measure Memphis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Memphis Pharmaceuticals is operating at the current time. Most of Memphis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Memphis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Memphis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Memphis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |